Jiangsu Wanbang Biochemical Pharmaceutical Group Co., Ltd. (abbreviated as Wanbang Pharmaceutical) is a core member enterprise of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (abbreviated as Fosun Pharma, stock code: 600196-SH, 02196-HK). The company originated from Xuzhou Biochemical Pharmaceutical Factory, established in 1981; in 1998, it was restructured into Xuzhou Wanbang Biochemical Pharmaceutical Co., Ltd.; in 2001, it was renamed Jiangsu Wanbang Biochemical Pharmaceutical Co., Ltd.; in 2004, it joined Fosun Pharma; in 2017, it was upgraded to Jiangsu Wanbang Biochemical Pharmaceutical Group Co., Ltd. Wanbang Pharmaceutical has built first-class domestic R&D and production bases for prokaryotic and eukaryotic cell genetic engineering drugs. Its R&D of recombinant protein drugs such as recombinant human insulin and its analogs, erythropoietin, etc., leads the domestic field. Through equity participation, it has established a small-molecule innovative drug R&D laboratory in San Francisco, USA; it also holds a leading position in high-difficulty small-molecule generic drugs. The company invests about 10% of its annual sales revenue in new drug R&D; it has a full-time R&D team of over 500 people, of which more than 50% hold master's or doctoral degrees. It applies for more than 40 national patents annually and launches several new products each year. Wanbang Pharmaceutical currently holds controlling management of 20 member enterprises and has 10 production bases nationwide, covering a total area of over 1,000 mu. The company possesses business qualifications for drug production, wholesale, chain stores, and internet sales. Recently, the company invested RMB 600 million to design and build a biological products workshop and a formulation joint plant that meet cGMP standards according to European and American pharmaceutical management concepts, with key production and testing equipment being world-class. Wanbang Pharmaceutical's mission: We promise health with our heart! Wanbang Pharmaceutical's vision: To be a respected, innovation-led, first-class pharmaceutical enterprise!
What does Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd. require? Who is Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd. hiring? recruitment: 销售类占比最多占48.5%，其次是经营管理类占21.5%. What education can get in at ? 大专占比最多占44.6%，其次是本科占40.3%. High education required at ? 硕士占12.4%，博士占1.7%. Work experience required at ? 1-3年占比最多占35.2%，其次是5-10年占31.3%. Where are the job locations at ? 徐州占比最多占33%，其次是上海占18.9%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
